Welcome to Forbes for January 3rd, 2011 from Audible. This edition contains seven feature articles.
The cover story is "Gene Machine" - Jonathan Rothberg's desktop decoder could kick off a revolution in medicine, food, energy, even consumer products--and ignite the next $100 billion technology market.
Also, "The Man Behind Oprah" - David Zaslav is a longtime TV exec, but his new Oprah Winfrey Network will define him--one way or another.
Next, "Under the Gun" - As Pentagon budgets shrink, Linda Hudson must transform defense giant BAE Systems. It will not be easy or cheap.
We'll also tell you about "Genome Hackers" - In an era of cheap gene scans and vast DNA databases, will consumers be able to keep their sensitive genetic information private?
Then, "Shrink It, Cure It" - GlaxoSmithKline Chief Andrew Witty has a plan to save the struggling drugmaker: Turn it into a collection of entrepreneurial biotech outfits.
Followed by "The Resurrection of Alan Schwartz" - Humbled by the collapse of Bear Stearns he has found a new life--and new challenges--in turning Guggenheim Partners into Wall Street's newest comer.
And in our final story "One Pharma Entrepreneur's Never Ending Quest" Lisa Conte mustered $200 million to make prescription drugs from plants. Payoff may be in sight.
© and (P) 2010 Forbes
There are no listener reviews for this title yet.
Report Inappropriate Content
If you find this review inappropriate and think it should be removed from our site, let us know. This report will be reviewed by Audible and we will take appropriate action.